PuSH - Publication Server of Helmholtz Zentrum München

Sperk, A.* ; Gabriel, A.* ; Koch, D.* ; Augsburger, A.* ; Sanchez, V.* ; Brockelt, D.* ; Öllinger, R.* ; Engleitner, T.* ; Giansanti, P.* ; Ludwig, R. ; Auf der Maur, P.* ; Walter, W.* ; Haferlach, T.* ; Jeremias, I. ; Rad, R.* ; Steigenberger, B.* ; Kuster, B.* ; Eichner, R.* ; Bassermann, F.*

FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells.

Leukemia, DOI: 10.1038/s41375-024-02345-0 (2024)
Publ. Version/Full Text DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Letter to the Editor
Corresponding Author
ISSN (print) / ISBN 0887-6924
e-ISSN 1476-5551
Journal Leukemia
Publisher Nature Publishing Group
Publishing Place Campus, 4 Crinan St, London, N1 9xw, England
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
Grants Swiss National Science Foundation
TUM Innovation Network Grant (NextGenDrugs)
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
European Research Commission (ERC)
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)